Epstein-Barr virus: the first human tumor virus and its role in cancer.
about
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesViruses associated with human cancerThe viral etiology of AIDS-associated malignanciesCRISPR/Cas9 and cancer targets: future possibilities and present challengesMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaViruses and human cancers: a long road of discovery of molecular paradigms.A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytesDifferential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirusIntracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.Viral transformation for production of personalized type I interferonsgamma-Herpesvirus-induced protection against bacterial infection is transient.Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Comprehensive cancer centres and the war on cancer.Persistent gamma-herpesvirus infections: what can we learn from an experimental mouse model?Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymesInterferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines.Replication and transcription activator (RTA) of murine gammaherpesvirus 68 binds to an RTA-responsive element and activates the expression of ORF18The CRISPR/Cas9 genome editing methodology as a weapon against human virusesDetection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphomaCRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC InfectionEpstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model.Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal StudyHoloendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation.Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis.Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinomaInterferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic propertiesOral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review.Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.Immunohistochemical Study EMT-Related Proteins in HPV-, and EBV-Negative Patients with Sinonasal Tumours.The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System.Nuclear factor κB represses the expression of latent membrane protein 1 in Epstein-Barr virus transformed cells.The IRF family of transcription factors: Inception, impact and implications in oncogenesis.Periodontitis lesions are a source of salivary cytomegalovirus and Epstein-Barr virus.
P2860
Q24646670-460023F8-1C89-4064-A9F7-C44FE1464715Q24653900-CD003D11-9CFE-4A8F-8123-79701CF11353Q24685892-E211AA94-3B95-45EE-B4E5-AA1E9B6C8BE6Q26769907-40AAFC20-E9CE-4FD7-8948-198C8545F47FQ28472086-E490C9A4-E303-4203-8E49-236B3C1E5FEAQ30384388-BEE459ED-9E4B-4A9D-8916-BE6CF7257637Q30496656-DCA99333-B126-4F06-90DA-1ADEFA959B29Q30979226-209E32FB-16E2-4494-A00B-A0A3149BBF7DQ33745898-5178ACAC-953E-4BE6-85CD-86B5FD77CE59Q33870488-239D7B2F-1171-4CE0-B916-9BA187A421B0Q34118602-B75F502A-CC5E-49E4-8CDC-8706C33E05D0Q34186031-517BE013-E54E-46AF-ABEB-82C816F806B3Q34341797-0B3096AC-3271-41A0-91BF-6F733353AF6BQ34346992-C57FC42B-49A1-4B83-A79A-39F9FF193E4BQ34405076-4A7C204B-21A1-4F7B-9B67-8C642A38CF5CQ34570106-18BD55F2-AB89-417C-9EB7-4EEB117E2D07Q34584067-B91079F5-3A7F-4DDE-A435-648F50EEFF12Q34789389-2F4ECF95-20E7-4D9A-A2F2-CB7DE00BBA27Q34979127-C2EE8C74-32F5-4807-BEE8-2F70D0D6CB7AQ35363169-BD1A4998-059F-43FC-99EC-04DBBA2A54F2Q35363402-566EDC40-D53E-47E1-ABF3-31E7B73E763AQ35654689-A2305721-12ED-4258-A516-512826A69255Q35662608-61FB65FE-EBF2-4BC7-8B94-17B854E5EC59Q35770584-EA98CC65-8793-4660-A94D-C87E9F814BDFQ36099024-98D6152B-D6EF-4A84-AFB9-1171683DCCEDQ36235726-431465CB-3A43-42B6-848E-2D446B561F3AQ36559910-9E80ECC0-075C-4945-BE36-627574F1A61EQ36692186-D540B468-8FAB-477D-A2A8-898564CE532FQ37295787-289BD6B9-77A3-4A22-B8E9-2686A002ECEFQ37596432-B41652B3-6306-4080-85AF-2670625F4401Q38545129-8D66E1F5-FDC4-463F-8A9D-AEEF988F3EDAQ38631755-A009D192-75C2-45E2-8A2D-11CDB3A1E560Q38944897-7A6CFAC7-B633-45CA-AC54-6B15F3878A47Q39593759-DBA519D2-47AF-429E-8600-F3BC41E91C2BQ40155828-7AC8744F-037E-4716-AC39-BE7A8164175BQ40772276-2BADDA74-BB6A-4C42-85A6-885DB83F75D0Q41035560-800917CE-7811-4C96-826F-DE2A7541DA36Q41662260-B709563B-012B-4CF4-B20F-8C2A6D874A76Q41888239-A596E67C-8B1C-4240-A18C-825847865D20Q44243169-77B989DA-8D3C-472D-B5B5-38D41C090E3C
P2860
Epstein-Barr virus: the first human tumor virus and its role in cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@ast
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@en
type
label
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@ast
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@en
prefLabel
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@ast
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@en
P2860
P1476
Epstein-Barr virus: the first human tumor virus and its role in cancer.
@en
P2093
P2860
P304
P356
10.1046/J.1525-1381.1999.T01-1-99220.X
P577
1999-11-01T00:00:00Z